Position in RGC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$68,200
-$684,222 QoQ
Shares Held
11,199
-62.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 35 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vident Advisory, LLC holds $34,283,611 across 24 Drug Manufacturers - Specialty & Generic names. RGC ranks #24 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
317,141 | $5,036,196 | |
| 2 | ALKS |
Alkermes plc.
|
84,111 | $4,407,415 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
6,535 | $3,540,857 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
187,312 | $2,714,150 | |
| 5 | ZTS |
Zoetis Inc.
|
33,892 | $2,435,477 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
143,921 | $2,307,052 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
13,348 | $2,249,670 | |
| 8 | HLN |
Haleon plc
|
214,226 | $1,998,728 |
All Filings in RGC
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,200 | 11,199 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $752,422 | 29,588 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $628,614 | 29,934 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $279,150 | 18,068 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||